Liver transplantation: Yesterday, today and tomorrow

World Journal of Gastroenterology

Volumn 14, Issue 20, 2008, Pages 3117-3122

  Abbasoglu, Osman ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

ABO incompatibility; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Liver transplantation; Living donor

Indexed keywords

HEPATITIS B ANTIBODY; HLA ANTIGEN; LAMIVUDINE; PEGINTERFERON; RIBAVIRIN;

BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; CHRONIC LIVER DISEASE; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EDITORIAL; GASTROENTEROLOGY; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HLA SYSTEM; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; MORBIDITY; OFF PUMP SURGERY; RECURRENT DISEASE; RISK BENEFIT ANALYSIS; RISK REDUCTION; SURGICAL MORTALITY; VIRUS HEPATITIS;

EID: 48949104906     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.3117     Document Type: Editorial

References (50)

1. Groth CG, Brent LB, Calne RY, Dausset JB, Good RA, Murray JE, Shumway NE, Schwartz RS, Starzl TE, Terasaki PI, Thomas ED, van Rood JJ. Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles. World J Surg 2000;24:834-843
2. Starzl TE. History of clinical transplantation. World J Surg 2000;24:759-782
3. Raia S, Nery JR, Mies S. Liver transplantation from live donors. Lancet 1989; 2: 497
4. Japanese Liver Transplantation Society. Liver transplantation in Japan: registry by the Japanese Liver Transplantation Society. Jap J Transpl 2003; 38: 401-408
5. Shneider BL, Emre S. Pediatric liver transplantation: past, present, and future. Liver Transpl 2006; 12: 511-513
6. Malago M, Burdelski M, Broelsch CE. Present and future challenges in living related liver transplantation. Transplant Proc 1999; 31:1777-1781
7. Pomfret EA, Pomposelli JJ, Lewis WD, Gordon FD, Burns DL, Lally A, Raptopoulos V, Jenkins RL. Live donor adult liver transplaritation using right lobe grafts: donor evaluation and surgical outcome. Arch Surg 2001; 136: 425-433
8. Grewal HP, Shokouh-Amiri MH, Vera S, Stratta R, Bagous W, Gaber AO. Surgical technique for right lobe adult living donor liver transplantation without venovenous bypass or portocaval shunting and with duct-to-duct biliary reconstruction. Ann Surg 2001; 233: 502-508
9. Tanaka K. Progress and future in living donor liver transplantation. Keio J Med 2003; 52: 73-79
10. Sugawara Y, Makuuchi M. living donor liver transplantation: present status and recent advances. Br Med Bull 2005; 75: 15-28
11. Kawasaki S, Makuuchi M, Matsunami H, Hashikura Y, Ikegami T, Nakazawa Y, Chisuwa H, Terada M, Miyagawa S. Living related liver transplantation in adults. Ann Surg 1998; 227: 269-274
12. Lo CM, Fan ST, Liu CL, Chan JK, Lam BK, Lau GK, Wei WI, Wong J. Minimum graft size for successful living donor liver transplantation. Transplantation 1999; 68: 1112-1116
13. Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, Egawa H, Fujita S, Hayashi M, Tanaka K. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 1999; 67: 321-327
14. Ben-Haim M, Emre S, Fishbein TM, Sheiner PA, Bodian CA, Kim-Schluger L, Schwartz ME, Miller CM. Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl 2001; 7: 948-953
15. Ghobrial RM, Busuttil RW. Future of adult living donor liver transplantation. Liver Transpl 2003; 9: S73-S79
16. Lee SG. Asian contribution to living donor liver transplantation. J Gastroenterol Hepatol 2006; 21: 572-574
17. Abbasoglu O, Levy MF, Brkic BB, Testa G, Jeyarajah DR, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation 1997; 64: 1801-1807
18. Gane EJ, Angus PW, Strasser S, Crawford DH, Ring J, Jeffrey GP, McCaughan GW. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology 2007; 132: 931-937
19. Takaki A, Yagi T, Iwasaki Y, Sadamori H, Matsukawa H, Matsuda H, Shinoura S, Umeda Y, Miyake Y, Terada R, Kobashi H, Sakaguchi K, Tanaka N, Shiratori Y. Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation. Transplantation 2007; 83: 231-233
20. Gornals JB, Casanovas T, Sabido M, Baliellas C, Casanovas A, Canas C, Serrano T, Verdura B, Chahri N, Gil-Vernet S, Figueras J. Clinical and virological effects during two years of ongoing adefovir dipivoxil in the treatment of lamivudine-resistant chronic hepatitis B infection. Transplant Proc 2005; 37: 3957-3959
21. Eisenbach C, Sauer P, Mehrabi A, Stremmel W, Encke J. Prevention of hepatitis B virus recurrence after liver transplantation. Clin Transplant 2006; 20 Suppl 17: 111-116
22. Johnson MW, Washburn WK, Freeman RB, FitzMaurice SE, Dienstag J, Basgoz N, Jenkins RL, Cosimi AB. Hepatitis C viral infection in liver transplantation. Arch Surg 1996; 131: 284-291
23. Rosen HR, O'Reilly PM, Shackleton CR, McDiarmid S, Holt C, Busuttil RW, Martin P. Graft loss following liver transplantation in patients with chronic hepatitis C. Transplantation 1996; 62: 1773-1776
24. Russo MW, Galanko J, Beavers K, Fried MW, Shrestha R. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl 2004; 10: 340-346
25. Riediger C, Berberat PO, Sauer P, Gotthardt D, Weiss KH, Mehrabi A, Merle U, Stremmel W, Encke J. Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation. Nephrol Dial Transplant 2007; 22 Suppl 8: viii37-viii46
26. Kornberg A, Kupper B, Tannapfel A, Barthel E, Thrum K, Settmacher U. Antiviral maintenance treatment with interferon and ribavirin for recurrent hepatitis C after liver transplantation: pilot study. J Gastroenterol Hepatol 2007; 22: 2135-2142
27. Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell A, Maluf D, Posner MP, Fisher RA. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 2004; 10: 1248-1255
28. Gaglio PJ, Malireddy S, Levitt BS, Lapointe-Rudow D, Lefkowitch J, Kinkhabwala M, Russo MW, Emond JC, Brown RS Jr. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transpl 2003; 9: 1028-1035
29. Petrovic LM. Early recurrence of hepatitis C virus infection after liver transplantation. Liver Transpl 2006, 12: S32-S37
30. Ikeda T, Yanaga K, Kishikawa K, Kakizoe S, Shimada M, Sugimachi K. Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology 1992; 16: 454-461
31. Abt P, Crawford M, Desai N, Markmann J, Olthoff K, Shaked A. Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation 2003; 75: 1659-1663
32. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, Markmarm JF. Survival following liver transplantation from non-heart-beating donors. Ann Surg 2004; 239: 87-92
33. Reddy S, Zilvetti M, Brockmann J, McLaren A, Friend P. Liver transplantation from non-heart-beating donors: current status and future prospects. Liver Transpl 2004; 10: 1223-1232
34. Kassahun WT, Fangmann J, Harms J, Hauss J, Bartels M. Liver resection and transplantation in the management of hepatocellular carcinoma: a review. Exp Clin Transplant 2006; 4: 549-558
35. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatorellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699
36. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002; 8: 765-774
37. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-524
38. Sutcliffe R, Maguire D, Portmann B, Rela M, Heaton N. Selection of patients with hepatocellular carcinoma for liver transplantation. Br J Surg 2006; 93: 11-18
39. Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002; 8: 873-883
40. Sarasin FP, Giostra E, Mentha G, Hadengue A. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology 1998; 28: 436-442
41. Furukawa H, Shimamura T, Suzuki T, Taniguchi M, Yamashita K, Kamiyama T, Matsushita M, Todo S. Living-donor liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2006; 13: 393-397
42. Cheng SJ, Pratt DS, Freeman RB Jr, Kaplan MM, Wong JB. Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis. Transplantation 2001; 72: 861-868
43. Sarasin FP, Majno PE, Llovet JM, Bruix J, Mentha G, Hadengue A. Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective. Hepatology 2001; 33: 1073-1079
44. Bigourdan JM, Jaeck D, Meyer N, Meyer C, Oussoultzoglou E, Bachellier P, Weber JC, Audet M, Doffoel M, Wolf P. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 2003; 9: 513-520
45. Facciuto ME, Koneru B, Rocca JP, Wolf DC, Kim-Schluger L, Visintainer P, Klein KM, Chun H, Marvin M, Rozenblit G, Rodriguez-Davalos M, Sheiner PA. Surgical Treatment of Hepatocellular Carcinoma beyond Milan Criteria. Results of Liver Resection, Salvage Transplantation, and Primary Liver Transplantation. Ann Surg Oncol 2008; 15: 1383-1391
46. Rydberg L. ABO-incompatibility in solid organ transplantation Transfus Med 2001; 11: 325-342
47. Skogsberg U, Breimer ME, Friman S, Mjornstedt L, Molne J, Olausson M, Rydberg L, Svalander CT, Backman L. Successful ABO-incompatible liver transplantation using A2 donors. Transplant Proc 2006; 38: 2667-2670
48. Heffron T, Welch D, Pillen T, Asolati M, Smallwood G, Hagedorn P, Nam C, Duncan A, Guy M, Martinez E, Spivey J, Douglas P, Fasola C, De Paolo J, Rodriguez J, Romero R. Successful ABO-incompatible pediatric liver transplantation utilizing standard immunosuppression with selective postoperative plasmapheresis. Liver Transpl 2006; 12: 972-978
49. Sugawara Y, Makuuchi M. Adult liver transplantation using live ABO-incompatible grafts in Western countries. Liver Transpl 2006; 12: 1324-1325
50. Middleton PF, Duffield M, Lynch SV, Padbury RT, House T, Stanton P, Verran D, Maddern G. Living donor liver transplantation--adult donor outcomes: a systematic review. Liver Transpl 2006; 12: 24-30